Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Accretion Pharmaceuticals Ltd
Your Vote -
Buy
66.67%
Hold
0.00%
Sell
33.33%
66.67%
3 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
NaN%
Sell Order Quantity
NaN%
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Accretion Pharmaceuticals Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Accretion Pharma - Action(s) taken or orders passed
-
Accretion Pharma - Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
-
Accretion Pharma - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Accretion Pharma - Analysts/Institutional Investor Meet/Con. Call Updates
-
Accretion Pharma - General Updates
-
Accretion Pharma - Analysts/Institutional Investor Meet/Con. Call Updates
-
Accretion Pharma - Analysts/Institutional Investor Meet/Con. Call Updates
-
Accretion Pharma - Analysts/Institutional Investor Meet/Con. Call Updates
-
Accretion Pharma - Analysts/Institutional Investor Meet/Con. Call Updates
-
Accretion Pharma - Analysts/Institutional Investor Meet/Con. Call Updates
-
Accretion Pharma - Investor Presentation
-
Accretion Pharma - Press Release
-
Accretion Pharma - Outcome of Board Meeting
-
Accretion Pharma - Analysts/Institutional Investor Meet/Con. Call Updates
-
Accretion Pharma - General Updates
-
Accretion Pharma has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025
-
Accretion Pharma - Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
-
Accretion Pharma - Certificate under SEBI (Depositories and Participants) Regulations, 2018
Key fundamentals
Evaluate the intrinsic value of Accretion Pharmaceuticals Ltd stock
| Name | March-25 | March-24 | March-23 | ||
|---|---|---|---|---|---|
| Assets | 29.39 | 18.8298 | 12.3085 | ||
| Liabilities | 29.39 | 18.8298 | 12.3085 | ||
| Equity | 8.17 | 4 | 3.8427 | ||
| Gross Profit | 11.8808 | 7.4894 | 1.9913 | ||
| Net Profit | 6.7935 | 3.8753 | 0.1039 | ||
| Cash From Operating Activities | 5.7499 | -3.8569 | 0.3212 | ||
| NPM(%) | 11.84 | 11.51 | 0.35 | ||
| Revenue | 57.3762 | 33.6652 | 29.3843 | ||
| Expenses | 45.4954 | 26.1758 | 27.393 | ||
| ROE(%) | 14.58 | 8.31 | 0.22 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Accretion Pharmaceuticals Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 749.55 | -1.88 | 0.00 | 0.00 | 301.39 | 0.67 |
| Lotus Eye Hospital and Institute Ltd | 115.48 | -2.15 | 360.88 | 0.00 | 3.55 | 0.00 |
| Vaishali Pharma Ltd | 8.48 | -2.42 | 0.00 | 0.00 | 3.13 | 0.00 |
| Astec Lifesciences Ltd | 664.80 | -3.32 | 0.00 | 0.00 | -604.77 | 0.00 |
Company Info
In the year 2012, our Promoters Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel, Mr. Mayur Popatlal Sojitra and Mr. Hardik Mukundbhai Prajapati, came together to establish a pharmaceutical manufacturing unit, with vision to provide health care products that match international quality standards at competitive price. Thus, the foundation of "Accretion Pharmaceuticals" was laid down, which was started as a Partnership Firm under the Partnership Act, 1932 ("Partnership Act") in the name and style of "M/s Accretion Pharmaceuticals", pursuant to a deed of partnership dated December 18, 2012. Our manufacturing facility which is currently located at 28 & 29 Xcelon Ind Park 1, B/H, Intas Pharmaceuticals, Vasna Chacharvadi, Ahmedabad, Sanand, Gujarat 382213, commenced its manufacturing operations in year 2014. Thereafter, pursuant to a resolution passed by the partners of M/s Accretion Pharmaceuticals on October 16, 2023, the Partnership Firm was converted into a Limited Company under Part I (Chapter XXI) of the Companies Act, 2013 in the name of "Accretion Pharmaceuticals Limited" and a certificate of incorporation dated November 29, 2023 was issued by the Registrar of Companies, Central Registration Centre, for and on behalf of the jurisdictional Registrar of Companies.The Corporate Identification Number of our Company is U21004GJ2023PLC146545.Major Events:2012- Formed as a Partnership Firm in the name and style of "M/s Accretion pharmaceuticals", pursuant to a deed of partnership dated December 18, 2012.2023-Incorporation of our Company "Accretion Pharmaceuticals Limited" as a Public Limited Company from conversion of "M/s Accretion Pharmaceuticals" a Partnership firm vide partner's resolution dated October 16, 2023.
In the year 2012, our Promoters Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel, Mr. Mayur Popatlal Sojitra and Mr. Hardik Mukundbhai Prajapati, came together to establish a pharmaceutical manufacturing unit, with vision to provide health care products that match international quality standards at competitive price. Thus, the foundation of "Accretion Pharmaceuticals" was laid down, which was started as a Partnership Firm under the Partnership Act, 1932 ("Partnership Act") in the name and style of "M/s Accretion Pharmaceuticals", pursuant to a deed of partnership dated December 18, 2012. Our manufacturing facility which is currently located at 28 & 29 Xcelon Ind Park 1, B/H, Intas Pharmaceuticals, Vasna Chacharvadi, Ahmedabad, Sanand, Gujarat 382213, commenced its manufacturing operations in year 2014. Thereafter, pursuant to a resolution passed by the partners of M/s Accretion Pharmaceuticals on October 16, 2023, the Partnership Firm was converted into a Limited Company under Part I (Chapter XXI) of the Companies Act, 2013 in the name of "Accretion Pharmaceuticals Limited" and a certificate of incorporation dated November 29, 2023 was issued by the Registrar of Companies, Central Registration Centre, for and on behalf of the jurisdictional Registrar of Companies.The Corporate Identification Number of our Company is U21004GJ2023PLC146545.Major Events:2012- Formed as a Partnership Firm in the name and style of "M/s Accretion pharmaceuticals", pursuant to a deed of partnership dated December 18, 2012.2023-Incorporation of our Company "Accretion Pharmaceuticals Limited" as a Public Limited Company from conversion of "M/s Accretion Pharmaceuticals" a Partnership firm vide partner's resolution dated October 16, 2023.
Read More
Parent Organisation
Accretion Pharmaceuticals Ltd.
Founded
18/12/2012
Managing Director
Mr.Vivek Ashok Kumar Patel
NSE Symbol
ACCPLST
FAQ
The current price of Accretion Pharmaceuticals Ltd is
The 52-week high for Accretion Pharmaceuticals Ltd is
The market capitalization of Accretion Pharmaceuticals Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Accretion Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Accretion Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Accretion Pharmaceuticals Ltd shares.
The CEO of Accretion Pharmaceuticals Ltd is Mr.Vivek Ashok Kumar Patel, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.